Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non–muscle-invasive Bladder Cancer
Roberto Contieri(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Jaromír Háček(Charles University), Michael Pešl(Charles University), Maximilian Seles(Medical University of Graz), Laura S. Mertens(Oncode Institute), Karin Plass(European Association of Urology), Francesco Soria(Medical University of Vienna), Irene Beijert(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), H.M. Bruins(Radboud University Nijmegen), J. Rubio‐Briones, Sebastian Mannweiler(Medical University of Graz), Otakar Čapoun(European Association of Urology), Jean‐François Côté(Héma-Québec), Fredrik Liedberg(Lund University), Alberto Martini(The University of Texas MD Anderson Cancer Center), Sonja Herdegen(University of Regensburg), David Ashabere(Royal Surrey County Hospital), Anouk E. Hentschel(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Dimitrios Volanis, Olivier Cussenot(Sorbonne Université), Lenka Bauerová(Charles University), Diana Turturica(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), V.R.M. Kusuma(Royal Surrey County Hospital), A. Brisuda(Charles University), Thomas Seisen(Sorbonne Université), Francesco Claps(The Netherlands Cancer Institute), Richard Zigeuner(European Association of Urology), Johannes Breyer(University of Regensburg), Daniel L. Cohen(European Association of Urology), Éva Compérat(Vienna General Hospital), José Daniel Subiela(Universidad de Alcalá), Willemien Runneboom(Radboud University Nijmegen), Francesca Pisano, Nicolai Huebner(Vienna General Hospital), Ana Calatrava(Fundación Instituto Valenciano de Oncología), Virginia Hernández(Hospital Universitario Fundación Alcorcón), Hugh Mostafid, A. Masson-Lecomte(Université Paris Cité), Andrea Haitel(University of Vienna), Jakko A. Nieuwenhuijzen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Luca Lunelli, Morgan Rouprêt(Sorbonne Université), José L. Domínguez-Escrig(Fundación Instituto Valenciano de Oncología), Shahrokh F Shariat(Cornell University), Oscar Rodríguez(Universitat Autònoma de Barcelona), Enrique de la Peña(Hospital Universitario Fundación Alcorcón), Johannes Bründl(University of Regensburg), Isabel Alemany(Hospital Universitario Fundación Alcorcón), Judith Bosschieter(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 11
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
|European Urology|2020|2.2k
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
|European Urology|2016|1.5k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
A Molecular Taxonomy for Urothelial Carcinoma
|Clinical Cancer Research|2012|1k
Multiple loci identified in a genome-wide association study of prostate cancer
|Nature Genetics|2008|907